From Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment:

Nerium Oleander—

Phoenix Biotechnology has an extract of the toxic nerium oleander plant, which it wants to make into a pharmaceutical drug. Image of nerium oleander in Hawaii taken by Forest & Kim Starr. Used with permission under Flickr creative commons license.

Underwriters and Partners

Xconomy Insight

Sponsored · Webinar
Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways
Robust, sensitive, & easy-to-use cell-based, reporter gene assays to study signaling pathways
Eurofins DiscoverX

Sponsored · Whitepaper
How to Approach Life Sciences Fundraising
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research
Brex

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

AMAG Pharma Sells Off Women’s Health Product in Planned Divestment

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug

Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

Vividion Gets $135M in Collaboration With Roche on Protein Degradation

Applied Molecular Plots IPO to Back Transport of Biologic Drugs to Gut

Synthorx’s Shawver Joins Silverback Therapeutics as New Top Exec

Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders

New COVID-19 Special Reports Explore Clinical Research During the Pandemic

BioCryst Pharma Appoints Anthony Doyle Chief Financial Officer

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

From Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment:

Underwriters and Partners

Simple Signaling Reporter Assays – Easily Quantify Activation & Inhibition of Cellular Pathways

How to Approach Life Sciences Fundraising

IBM Watson Health Data in Action – Epidemiology Studies

Xconomy on Demand

We offer a number of ways to subscribe for free!